Clinical Trials Directory

Trials / Completed

CompletedNCT01990781

Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness.

Combined Effect of Intravenous Lidocaine and Dexamethasone on Postoperative Sore Throat, Cough and Hoarseness. A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
180 (actual)
Sponsor
B.P. Koirala Institute of Health Sciences · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Post operative sore throat (POST) following tracheal intubation is a common problem causing dissatisfaction and discomfort to the patients. Prophylactic use of both lidocaine and dexamethasone has been used independently for this purpose. However, there is no study assessing the synergistic analgesic effects of lidocaine and dexamethasone for POST. The purpose of this study is to compare the effect of lidocaine, dexamethasone and lidocaine dexamethasone combination on the incidence and severity of POST.

Detailed description

Sore throat and hoarseness following tracheal intubation are common postoperative problems causing dissatisfaction and discomfort to the patients. Their incidence varies from 30%-70%. Both non pharmacological and pharmacological measures have been tried to minimize the incidence and severity of POST with variable success rate. Prophylactic use lidocaine and steroids have been used independently for this purpose. Dexamethasone as an adjuvant to lidocaine has shown to improve the quality of analgesia. However, there is no study assessing the combine effects of lidocaine and dexamethasone for POST.

Conditions

Interventions

TypeNameDescription
DRUGLD: Lidocaine and dexamethasoneLD: intravenous lidocaine 1.5 mg/kg and dexamethasone 8 mg before induction of anesthesia
DRUGL:LidocaineIntravenous lidocaine 1.5 mg/kg before induction of anesthesia
DRUGD: DexamethasoneD:intravenous dexamethasone 8 mg before induction of anesthesia
DRUGN: Normal saline (placebo)Normal saline: 2ml

Timeline

Start date
2013-12-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2013-11-21
Last updated
2016-11-07

Locations

1 site across 1 country: Nepal

Source: ClinicalTrials.gov record NCT01990781. Inclusion in this directory is not an endorsement.